Clinical Trial Update: Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18 [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating HPV-16/18 vaccine efficacy against cervical pre-cancer in young adults has completed and results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer Precursor Lesions
• Cervical Intraepithelial Neoplasia

Drugs mentioned

• HPV-16/18 vaccine (Cervarix)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Papillomavirus | Phase 3 | Status: COMPLETED | Results posted: 2010-01-20